These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21146216)

  • 1. The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia.
    Liu Y; Wang Z; Jiang M; Dai L; Zhang W; Wu D; Ruan C
    Leuk Res; 2011 Jul; 35(7):879-84. PubMed ID: 21146216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The annexin A2 system and vascular homeostasis.
    Flood EC; Hajjar KA
    Vascul Pharmacol; 2011; 54(3-6):59-67. PubMed ID: 21440088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A2 in Fibrinolysis, Inflammation and Fibrosis.
    Lim HI; Hajjar KA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Biology of Annexin A2: From Vascular Fibrinolysis to Innate Immunity.
    Hajjar KA
    Trans Am Clin Climatol Assoc; 2015; 126():144-55. PubMed ID: 26330668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?
    Mantha S; Tallman MS; Soff GA
    Curr Opin Hematol; 2016 Mar; 23(2):121-6. PubMed ID: 26760586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Abnormal Hemostasis and Fibrinolysis in Morbidity and Mortality of Acute Promyelocytic Leukemia.
    Kwaan HC; Weiss I; Tallman MS
    Semin Thromb Hemost; 2019 Sep; 45(6):612-621. PubMed ID: 31370070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorrhage in acute promyelocytic leukemia-fibrinolysis in focus.
    Sabljic N; Thachil J; Pantic N; Mitrovic M
    Res Pract Thromb Haemost; 2024 Jul; 8(5):102499. PubMed ID: 39130779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated hemostasis in acute promyelocytic leukemia.
    Hisada Y
    Int J Hematol; 2024 May; 119(5):526-531. PubMed ID: 38341391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma.
    Bønløkke ST; Fenger-Eriksen C; Ommen HB; Hvas AM
    Blood Adv; 2023 Nov; 7(22):7056-7066. PubMed ID: 37756519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Coagulopathy of Acute Promyelocytic Leukemia: An Updated Review of Pathophysiology, Risk Stratification, and Clinical Management.
    Hermsen J; Hambley B
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHock-INduced Endotheliopathy (SHINE): A mechanistic justification for viscoelastography-guided resuscitation of traumatic and non-traumatic shock.
    Bunch CM; Chang E; Moore EE; Moore HB; Kwaan HC; Miller JB; Al-Fadhl MD; Thomas AV; Zackariya N; Patel SS; Zackariya S; Haidar S; Patel B; McCurdy MT; Thomas SG; Zimmer D; Fulkerson D; Kim PY; Walsh MR; Hake D; Kedar A; Aboukhaled M; Walsh MM
    Front Physiol; 2023; 14():1094845. PubMed ID: 36923287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
    Baysal M; Gürsoy V; Hunutlu FC; Erkan B; Demirci U; Bas V; Gulsaran SK; Pinar IE; Ersal T; Kirkizlar TA; Atli EI; Kirkizlar HO; Ümit EG; Gürkan H; Ozkocaman V; Ozkalemkas F; Demir AM; Ali R
    Ann Hematol; 2022 May; 101(5):1049-1057. PubMed ID: 35190843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Annexins in Sepsis and COVID-19.
    Mui L; Martin CM; Tschirhart BJ; Feng Q
    Front Pharmacol; 2021; 12():735472. PubMed ID: 34566657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding Disorders in Primary Fibrinolysis.
    Franchini M; Zaffanello M; Mannucci PM
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia.
    Pei Y; Shi M; Song J; Niu X; Wei S; Dou L; Xiao M; Li D; Xu F; Bai Y; Sun K
    Cancer Manag Res; 2021; 13():4135-4146. PubMed ID: 34045900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in cancer treatment: a new therapeutic target, Annexin A2.
    Li Z; Yu L; Hu B; Chen L; Jv M; Wang L; Zhou C; Wei M; Zhao L
    J Cancer; 2021; 12(12):3587-3596. PubMed ID: 33995636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia.
    Ruhnke L; Stölzel F; Wagenführ L; Altmann H; Platzbecker U; Herold S; Rump A; Schröck E; Bornhäuser M; Schetelig J; von Bonin M
    Front Oncol; 2021; 11():666014. PubMed ID: 33937079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of annexin A2 is associated with impaired cell surface fibrinolysis and venous thromboembolism.
    Fassel H; Chen H; Ruisi M; Kumar N; DeSancho M; Hajjar KA
    Blood; 2021 Apr; 137(16):2221-2230. PubMed ID: 33512476
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.